August 5 (Reuters) - What matters in U. and global markets today , Editor-at-Large, Finance and Markets For all the doubts and handwringing, the S&P; 500 and Dow Jones are back at record highs after surging on Tuesday amid falling oil prices and the bumper earnings season.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
August 5 (Reuters) - Investors are pouring money into U. healthcare stocks, betting that improving earnings, rising dealmaking and attractive valuations will extend the sector's rebound after years of underperformance.
US stock futures edged higher on Wednesday as investors reacted to renewed hopes of easing tensions in the Middle East, while corporate earnings from SpaceX (NASDAQ:SPCX), Advanced Micro Devices (NASDAQ:AMD) and Novo Nordisk (NYSE:NVO) drove significant pre-market trading. Although geopolitical developments supported overall market sentiment, investors also assessed company-specific news, particularly Elon Musk’s latest comments, which weighed on both SpaceX and AMD shares.
Sacrificing additional transparency is a dangerous game to play.
President Donald Trump discussed efforts to de-escalate US-Iran tensions with Qatari Emir Tamim bin Hamad Al Thani.
Hard drive makers Sandisk and Western Digital are due to report earnings after the closing bell Wednesday.
Korean memory-chip manufacturer SK Hynix late last month booked roughly $65 billion in profit for the quarter ended June 30, a 13-fold increase from last year. Hynix earned almost as much money in 90 days as it had in the prior 29 years since its IPO, total. The reports, though outstanding on basically every measure, still fell short of Wall Street’s sky-high expectations for chip companies.
Shares plunged 10% after reports tied a food-safety issue to produce at multiple locations, on Aug. 4, 2026.
CVS Health reports earnings Wednesday, with analysts expecting another solid quarter and looking for potential guidance upside from its Aetna insurance and Caremark pharmacy-benefit businesses.
The entertainment company is set to report fiscal third-quarter earnings ahead of Wednesday’s opening bell.
The Danish drugmaker continues to rely on the success of semaglutide, branded as Wegovy for weight loss and Ozempic for diabetes.
Autodesk currently trades at $246.30 per share and has shown little upside over the past six months, posting a small loss of 2.6%. The stock also fell short of the S&P 500’s 7.1% gain during that period.
Shares of one automation technology provider slipped after earnings, while another jumped. The new $13.15 midpoint implies fourth quarter earnings per share of about $3.60. Shares of automation technology provider Zebra Technologies were up 20% at $350 after it reported better-than-expected fiscal second-quarter numbers.
Investing.com -- Societe Generale told clients in a note on Tuesday that U.S. earnings strength is broadening beyond technology, and it expects the S&P 500 to reach 8,000, urging investors to "buy the momentum dip."
The number you need to know on Palantir right after earnings.
Investing.com - U.S. stock index futures rose on Tuesday as investors weighed mixed signals surrounding renewed Middle East peace talks while awaiting quarterly results from Elon Musk’s SpaceX, with semiconductor shares finding support from another round of upbeat AI-related earnings.
The drugmaker posts a narrower-than-expected quarterly loss fueled by growth in its oncology segment.